Sustained cytokinemia and chemokinemia concomitant with juvenile myelomonocytic leukemia in an infant with Noonan syndrome

Leuk Res. 2010 Sept;34(9), Kaoru Okazaki, Jun Unemoto, Masatoshi Kondo, Takashi Kusaka, Kunihisa Kozawa, Masakazu Yoshizumi, Akira Shimada, Junko Takita, Takashi Kaneko, Takehiro Hama, Hirokazu Kimura

1IntroductionNoonan syndrome (NS) is a multiple congenital abnormality syndrome with a prevalence of around 1 in 15,000 [1]. NS can be complicated by various hematologic derangements, including juvenile myelomonocytic leukemia (JMML) [1,2]. JMML itself is responsible for approximately 2% of juvenile leukemia cases and the outcome is extremely poor. Although most cases of JMML with NS show spontaneous remission, a small number of cases can be refractory and lethal, and their mechanisms are as yet...

NOT A MEMBER?

Registration is FREE

  • Up-to-date oncology news
  • Journal article summaries
  • Commentaries and interviews
  • Drug and interactions database
  • Chemotherapy regimens
  • Daily e-newsletters

 

Editors' Choice

Long-Term Posttransplant Bortezomib Boosts Outcome in Myeloma With del(17p13)

Sign up for our newsletters

Too busy to follow cancer's top stories? Sign-up for 1 or more of our free newsletters -- delivered weekly to your inbox.

Cancer Type

  • Bladder
  • Bone
  • Breast
  • Breast (ER-Positive)
  • CNS/Brain
  • Colon and Rectum
  • Endocrine System
  • Esophagus
  • GYN (Non-Ovary)
  • GYN (Ovary)
  • Head and Neck
  • Hodgkin's Lymphoma
  • Kidney (Renal Cell)
  • Leukemia
  • Liver and Bile Duct
  • Lung
  • Multiple Myeloma
  • Myelodysplastic Syndrome
  • Myeloproliferative Diseases
  • Non-Hodgkin's Lymphoma
  • Pancreas
  • Pediatric Cancers
  • Prostate
  • Rare Cancers
  • Skin
  • Soft-Tissue Sarcoma
  • Stomach
  • Testicle
  • Forgot your password?
    Not a member? Free registration